EMEA-002091-PIP01-16
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0110/2017
|
| PIP number |
EMEA-002091-PIP01-16
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Treatment of hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
CIPROS S.r.l.
E-mail: regolatorio@ciprossrl.it
Tel.: +39 573474010 Fax: +39 573475188 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|